Home › Type 2 Diabetes › Kansas
Type 2 Diabetes clinical trials in Kansas
14 studies for Type 2 Diabetes are looking for participants at sites in Kansas.
Cities in Kansas
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Lenexa
- Research Site, Newton
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07784270A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
- Cotton O'Neil Mulvane, Topeka
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT07754461A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Kansas City
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT07743450EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- AMR El Dorado, El Dorado
- Cotton O'Neil Diabetes & Endocrinology Center, Topeka
- Tekton Research - Wichita, Wichita
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT07064473A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
- Cotton O'Neil Diabetes & Endocrinology, Topeka
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 11, 2026 · NCT07668388A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
- Research Site, Wichita
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT07662213Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
- Alliance for Multispecialty Research - Wichita East, Wichita
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT07296484Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
- Alliance for Multispecialty Research Newton, Newton
- Alliance for Multispecialty Research LLC, Wichita
RecruitingPhase 3
Ages 18 to 99 · All sexes · Updated Sep 3, 2026 · NCT07684144AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
- Cotton O'Neil Diab & Endo Ctr, Topeka
RecruitingPhase 3
Ages 45 and older · All sexes · Updated Sep 1, 2026 · NCT07797335A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
- Research Site, El Dorado
- Research Site, Newton
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 31, 2026 · NCT07662044A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies
- Research Site, El Dorado
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 25, 2026 · NCT07606066Knee Osteoarthritis Treatment With Zilretta vs. Kenalog in the Context of Type II Diabetes
- University of Kansas Medical Center, Kansas City
RecruitingPhase 4
Ages 40 and older · All sexes · Updated May 28, 2026 · NCT06478186HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes
- AMR Clinical - El Dorado, El Dorado
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Apr 23, 2026 · NCT07546929Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus
- AMR Clinical, El Dorado, El Dorado
- AMR Clinical - Newton, Newton
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Mar 18, 2026 · NCT07282743From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.